An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease
- PMID: 28473469
- PMCID: PMC5473231
- DOI: 10.1074/jbc.M117.779215
An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease
Abstract
Inflammatory bowel diseases (IBDs) are a set of complex and debilitating diseases for which there is no satisfactory treatment. Recent studies have shown that small peptides show promise for reducing inflammation in models of IBD. However, these small peptides are likely to be unstable and rapidly cleared from the circulation, and therefore, if not modified for better stability, represent non-viable drug leads. We hypothesized that improving the stability of these peptides by grafting them into a stable cyclic peptide scaffold may enhance their therapeutic potential. Using this approach, we have designed a novel cyclic peptide that comprises a small bioactive peptide from the annexin A1 protein grafted into a sunflower trypsin inhibitor cyclic scaffold. We used native chemical ligation to synthesize the grafted cyclic peptide. This engineered cyclic peptide maintained the overall fold of the naturally occurring cyclic peptide, was more effective at reducing inflammation in a mouse model of acute colitis than the bioactive peptide alone, and showed enhanced stability in human serum. Our findings suggest that the use of cyclic peptides as structural backbones offers a promising approach for the treatment of IBD and potentially other chronic inflammatory conditions.
Keywords: NF-κB (NF-KB); SFTI-1; TNBS; colitis; cyclic peptide; nuclear magnetic resonance (NMR); peptide chemical synthesis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article.
Figures








References
-
- Ament M. E. (1975) Inflammatory disease of the colon: ulcerative colitis and Crohns colitis. J. Pediatr. 86, 322–334 - PubMed
-
- Strong S. A. (2001) Surgical management of Crohn's disease. In Surgical treatment: Evidence-based and problem-oriented (Holzheimer R.G., and Mannick J.A., eds), pp. 1–8, Zuckschwerdt, Munich - PubMed
-
- Navarro S., Ferreira I., and Loukas A. (2013) The hookworm pharmacopoeia for inflammatory diseases. Int. J. Parasitol. 43, 225–231 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical